Form 4: HeartBeam CFO Tim Cruickshank Increases Stake in BEAT
Insider Transaction Report
HeartBeam CFO Tim Cruickshank purchased 31,250 shares of common stock as part of the company's recent public offering.
Summary
- CFO Tim Cruickshank acquired 31,250 shares of HeartBeam, Inc. (BEAT) common stock.
- The purchase was executed at a price of $0.80 per share.
- The transaction occurred on April 16, 2026, in connection with the company's underwritten public offering.
- Following this transaction, the reporting person holds a total of 72,230 shares.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as the CFO's decision to invest personal capital in the company's public offering suggests confidence in the firm's future prospects.
Positives
- Insider confidence is demonstrated by the CFO's direct purchase of company stock.
- The purchase aligns the executive's financial interests with those of the shareholders.
Negatives
- The purchase was made at a price point reflecting the recent public offering valuation.
Risks
- Reliance on public offerings for capital can lead to shareholder dilution.
Future Outlook
The filing does not provide forward-looking guidance, as it is a disclosure of an insider transaction related to a completed public offering.
Industry Context
StockSavvy.ai notes that insider buying during a public offering is often viewed as a positive signal of management's belief in the company's long-term strategic direction, particularly in the medical technology sector.
Comparison to Industry Standards
- Insider participation in public offerings is a standard practice for aligning management incentives with capital raising activities.
- The purchase size is consistent with typical executive equity participation levels for small-cap medical device companies.
Stakeholder Impact
- Shareholders may interpret the CFO's purchase as a sign of stability and confidence in the company's recent capital raise.
Next Steps
- Continued monitoring of insider ownership filings for further changes in executive holdings.
Key Dates
| Date | Description |
|---|---|
| 2025-10-03 | Date of previous Form 4 filing regarding RSU vesting. |
| 2026-04-14 | Pricing date of the underwritten public offering. |
| 2026-04-16 | Transaction date and closing date of the public offering. |
Keywords
HeartBeam, BEAT, Insider Trading, CFO, Public Offering, Equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.